Antiplatelet therapy for transient ischaemic attacks and acute minor strokes: current best practice and future

dc.contributor.author	Mettananda, K.C.D.
dc.date.accessioned	2021-06-25T14:42:31Z
dc.date.available	2021-06-25T14:42:31Z
dc.date.issued	2021
dc.identifier.citation	Journal of the Ceylon College of Physicians.2021; 52(1):26–29.	en_US
dc.identifier.issn	2448-9514
dc.identifier.uri	http://repository.kln.ac.lk/handle/123456789/22862
dc.description	Not indexed in MEDLINE	en_US
dc.description.abstract	ABSTRACT: In patients presenting with transient ischaemic attacks and acute minor noncardioembolic ischemic strokes (NIHSS score ≤3) who did not receive intravenous alteplase, treatment with dual antiplatelet therapy with aspirin and clopidogrel, started within 24 hours of symptom onset and continued for 21 days is effective in reducing a recurrent ischemic stroke up to 90 days from the symptom onset. However, as the long-term risk of major disabling bleeding with aspirin-based antiplatelet treatment is higher in patients aged 75 years or older, routine co-prescription of proton pump inhibitor should be encouraged. KEYWORDS: Antiplatelet, Stroke, Transient-ischaemicattack, Prevention, Dual-antiplatelet	en_US
dc.language.iso	en_US	en_US
dc.publisher	Ceylon College of Physicians	en_US
dc.subject	Antiplatelet therapy	en_US
dc.title	Antiplatelet therapy for transient ischaemic attacks and acute minor strokes: current best practice and future	en_US
dc.type	Article	en_US

Files in this item

Name: Antiplatelet therapy ...

Size: 111.1Kb

Format: PDF

Journal/Magazine Articles
Articles published in local and international journals by the Staff of the Faculty of Medicine